Chimeric Therapeutics Competitors and Similar CompaniesClear all
Spur Therapeutics's competitors and similar companies include Polyplus-transfection and Codiak Biosciences.
 Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. |  Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. | |
Founding Date | Founding Date 2015 | Founding Date 2002 | Founding Date 2015 |
Type | Type Subsidiary | Type Private | Type Public |
Tags | |||
Locations | Locations Stevenage, GB HQ Boston, US New York, US | Locations Illkirch-Graffenstaden, FR HQ New York, US | Locations Cambridge, US HQ |
Employees | Employees 122 | Employees 1133% increase | Employees 992% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $22.9m (FY, 2021) |
Net income | Net income ($89m) (FY, 2022) | Net income N/A | Net income ($37.2m) (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised $ 289.3m | Total funding raised $ 3.2m | Total funding raised $ 168.5m |
For sources of this data, please see the company profile
View Company Profiles
Polyplus-transfection
HQ
Illkirch-Graffenstaden, FR
Employees
113↑ 3% increase
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View companyCodiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View company